The TBI group included subjects showing an AD-typical profile of tau deposition, with regions of increased tau appearing during Braak stages I–IV, in addition to atypical-AD regions including the frontal and cingulate cortex (Fig. 2a). The gene discussed is MAPT; the disease is Alzheimer disease.